MORABITO, Nunziata
 Distribuzione geografica
Continente #
EU - Europa 9.811
NA - Nord America 7.571
AS - Asia 5.036
SA - Sud America 1.587
AF - Africa 139
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.158
Nazione #
US - Stati Uniti d'America 7.427
RU - Federazione Russa 5.183
SG - Singapore 2.169
CN - Cina 1.535
BR - Brasile 1.323
IE - Irlanda 1.181
SE - Svezia 1.112
DE - Germania 555
IT - Italia 521
HK - Hong Kong 512
FR - Francia 340
VN - Vietnam 273
FI - Finlandia 254
GB - Regno Unito 165
UA - Ucraina 153
IN - India 145
PL - Polonia 136
AR - Argentina 86
CA - Canada 69
TR - Turchia 55
EC - Ecuador 52
IQ - Iraq 51
MX - Messico 47
BD - Bangladesh 41
BE - Belgio 40
NL - Olanda 38
ZA - Sudafrica 34
CO - Colombia 32
VE - Venezuela 32
PK - Pakistan 31
JP - Giappone 29
AT - Austria 26
UZ - Uzbekistan 25
ES - Italia 23
ID - Indonesia 20
MA - Marocco 20
CL - Cile 18
PY - Paraguay 18
EG - Egitto 17
CI - Costa d'Avorio 16
KR - Corea 14
CZ - Repubblica Ceca 13
JO - Giordania 13
PH - Filippine 13
AE - Emirati Arabi Uniti 11
IL - Israele 11
KE - Kenya 11
LT - Lituania 11
SA - Arabia Saudita 11
UY - Uruguay 11
AU - Australia 10
AZ - Azerbaigian 10
MY - Malesia 10
DZ - Algeria 8
PE - Perù 8
TN - Tunisia 8
BG - Bulgaria 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
KZ - Kazakistan 7
NG - Nigeria 7
NO - Norvegia 7
NP - Nepal 7
HN - Honduras 6
RO - Romania 6
BH - Bahrain 5
BO - Bolivia 5
ET - Etiopia 5
GT - Guatemala 5
JM - Giamaica 5
AL - Albania 4
EE - Estonia 4
GE - Georgia 4
SN - Senegal 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
DK - Danimarca 3
IR - Iran 3
OM - Oman 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CM - Camerun 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MU - Mauritius 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BT - Bhutan 1
Totale 24.139
Città #
Moscow 1.438
Ashburn 1.195
Dublin 1.180
Singapore 1.169
Chandler 866
Dallas 749
Nyköping 584
Beijing 525
Hong Kong 471
Jacksonville 418
San Jose 342
The Dalles 269
Munich 247
Princeton 215
Dearborn 194
Medford 171
Messina 168
Lauterbourg 166
New York 163
Los Angeles 158
Ann Arbor 156
Cambridge 131
Des Moines 128
Warsaw 122
Boardman 117
Bremen 105
São Paulo 100
Ho Chi Minh City 98
Helsinki 90
Buffalo 72
Tianjin 72
Guangzhou 63
Wilmington 61
Jinan 60
Shenyang 60
Catania 56
Hanoi 56
Turku 55
Nanjing 53
Redondo Beach 53
Frankfurt am Main 51
Orem 49
San Mateo 45
Rio de Janeiro 44
Brussels 40
Pune 37
Belo Horizonte 36
Houston 35
Woodbridge 35
Seattle 34
Hebei 33
Santa Clara 33
Curitiba 30
Chennai 28
Haikou 28
Council Bluffs 27
Zhengzhou 27
Düsseldorf 26
Nanchang 26
Taizhou 26
Hangzhou 25
Ningbo 25
Strasbourg 25
Tokyo 23
Chicago 22
Johannesburg 22
Montreal 22
Baghdad 21
Boston 21
Brooklyn 21
Tashkent 21
Brasília 19
Fuzhou 19
London 19
Nuremberg 19
Guayaquil 18
Lancaster 18
Milan 18
Shanghai 18
Denver 17
Poplar 17
Porto Alegre 17
Abidjan 16
Manchester 16
Toronto 16
Amsterdam 15
Atlanta 15
Falls Church 15
Quito 15
Rome 15
Fremont 14
Goiânia 14
Hyderabad 14
San Francisco 14
Mumbai 13
Ribeirão Preto 13
Stockholm 13
Campinas 12
Changsha 12
Lahore 12
Totale 13.787
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 290
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 235
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 223
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 220
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 217
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 216
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 214
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 214
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 212
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 209
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 206
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 205
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 204
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 200
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 197
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 194
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 191
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 187
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 187
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 186
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 186
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 185
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 179
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 178
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 178
Cardiovascular effects of raloxifene hydrochloride 177
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 177
Amylasemia in uremics: a complex interpretation 176
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 175
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 171
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 170
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 170
Association between anxiety levels and osteoporosis in postmenopausal women. 169
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 166
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 165
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 163
Anxiety levels as risk factor for osteoporosis in postmenopausal women 163
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 163
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 163
Frailty and lipid profile in elderly hospitalized patients 162
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 161
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 161
Recombinant erythropoietin and hypertension 160
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 158
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 158
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 157
Amylasemia in uremics: a complex interpretation 156
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 156
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 155
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 155
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 153
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 153
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 153
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 153
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 153
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 152
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 152
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 151
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 151
Frailty modifications and prognostic impact in older patients admitted in acute care 151
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 148
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 148
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 148
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 148
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 145
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 145
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 145
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 145
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 143
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 143
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 143
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 143
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 142
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 140
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 140
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 140
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 140
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 139
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 138
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 138
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 138
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 137
Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation 136
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 136
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 136
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 136
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 135
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 135
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 135
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 135
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 135
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 135
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 134
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 134
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 134
Role of genetic pattern on bone mineral density in thalassemic patients 132
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 132
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 131
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 130
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 130
Totale 16.289
Categoria #
all - tutte 76.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 111 59 52
2021/20221.526 13 194 19 58 39 16 153 45 160 246 133 450
2022/20233.460 256 349 165 241 304 324 33 190 1.428 22 104 44
2023/2024923 67 137 43 99 66 200 36 90 6 20 17 142
2024/20254.005 64 74 68 259 216 99 128 784 991 298 351 673
2025/202611.667 618 878 749 800 998 2.503 1.498 1.630 1.569 424 0 0
Totale 24.541